These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39008470)

  • 1. In Situ Protein Expression Analysis of Melanocyte Differentiation Antigen TRP1 (Tyrosinase-Related Protein-1).
    Chen JM; Hernandez E; Frosina D; Ruh PA; Ariyan C; Busam KJ; Jungbluth AA
    Am J Dermatopathol; 2024 Sep; 46(9):563-571. PubMed ID: 39008470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.
    Avogadri F; Gnjatic S; Tassello J; Frosina D; Hanson N; Laudenbach M; Ritter E; Merghoub T; Busam KJ; Jungbluth AA
    Am J Dermatopathol; 2016 Mar; 38(3):201-7. PubMed ID: 26894771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
    Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
    J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers.
    Busam KJ; Kucukgöl D; Sato E; Frosina D; Teruya-Feldstein J; Jungbluth AA
    Am J Surg Pathol; 2005 Mar; 29(3):400-6. PubMed ID: 15725810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
    Clarkson KS; Sturdgess IC; Molyneux AJ
    J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus.
    Hashimoto Y; Ito Y; Kato T; Motokawa T; Katagiri T; Itoh M
    J Cutan Pathol; 2006 Mar; 33(3):207-15. PubMed ID: 16466507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
    Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
    Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.
    Busam KJ; Iversen K; Coplan KC; Jungbluth AA
    Am J Surg Pathol; 2001 Feb; 25(2):197-204. PubMed ID: 11176068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosinase and nestin immunohistochemical expression in melanocytic nevi as a histopathologic pattern to trace melanocyte differentiation and nevogenesis.
    Murtas D; Pilloni L; Diana A; Casula L; Tomei S; Piras F; Ferreli C; Maxia C; Perra MT
    Histochem Cell Biol; 2019 Feb; 151(2):175-185. PubMed ID: 30232588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
    Lohmann CM; Iversen K; Jungbluth AA; Berwick M; Busam KJ
    Am J Surg Pathol; 2002 Oct; 26(10):1351-7. PubMed ID: 12360050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
    Orchard GE
    Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
    Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
    Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
    Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
    Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
    Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
    Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
    Krengel S; Grotelüschen F; Bartsch S; Tronnier M
    J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of melanocyte-specific antibodies to human melanosomal proteins: expression patterns in normal human skin and in cutaneous pigmented lesions.
    Virador V; Matsunaga N; Matsunaga J; Valencia J; Oldham RJ; Kameyama K; Peck GL; Ferrans VJ; Vieira WD; Abdel-Malek ZA; Hearing VJ
    Pigment Cell Res; 2001 Aug; 14(4):289-97. PubMed ID: 11549113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.